Unmasked Tuberculosis and Tuberculosis Immune Reconstitution Inflammatory Disease: A Disease Spectrum after Initiation of Antiretroviral Therapy
Open Access
- 1 February 2009
- journal article
- case report
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 199 (3) , 437-444
- https://doi.org/10.1086/595985
Abstract
Antiretroviral therapy (ART) has beneficial effects on mortality and lowers the incidence of diseases caused by opportunistic infections, such as tuberculosis (TB). AlthoughARThas sustained long-term benefits, the risk ofTB is high during the first 3 months after ART initiation. Among cases of ART-associated TB, we define “unmasked TB” as that which occurs in patients with reactivation disease who develop clinically recognizable TB after ART with the restoration of previously acquired TB antigen-specific functional immune responses. TB cases with clinical evidence of an inflammatory syndrome are a subset of these unmasked cases, which we define as “unmasked TB-immune reconstitution inflammatory syndrome.” With more widespread use of ART in areas with a high prevalence of TB, unmasked TB will likely become more common. TB diagnostics with improved sensitivity and specificity are urgently needed to detect subclinical TB before it is unmasked.Keywords
This publication has 47 references indexed in Scilit:
- Immune Reconstitution and “Unmasking” of Tuberculosis during Antiretroviral TherapyAmerican Journal of Respiratory and Critical Care Medicine, 2008
- TuberculosisThe Lancet, 2007
- Tuberculosis after Initiation of Antiretroviral Therapy in Low-Income and High-Income CountriesClinical Infectious Diseases, 2007
- Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis controlAIDS, 2006
- Tuberculosis after HAART initiation in HIV-positive patients from five countries with a high tuberculosis burdenAIDS, 2006
- Incidence of Tuberculosis among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy in Europe and North AmericaClinical Infectious Diseases, 2005
- Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohortAIDS, 2005
- Does immune reconstitution syndrome promote active tuberculosis in patients receiving highly active antiretroviral therapy?AIDS, 2005
- Risk Factors for Active Tuberculosis after Antiretroviral Treatment Initiation in AbidjanAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Tuberculosis in HIV‐infected persons in the context of wide availability of highly active antiretroviral therapyEuropean Respiratory Journal, 2004